| 产品编号 | CFN60068 | |
| CAS编号 | 1001264-89-6 | |
| 分子式 = 分子量 | C24H32ClN5O2 = 458.0 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| Ipatasertib (GDC-0068) | CFN60068 | 1001264-89-6 | 1mg | QQ客服:1457312923 |
| Ipatasertib (GDC-0068) | CFN60068 | 1001264-89-6 | 5mg | QQ客服:1457312923 |
| Ipatasertib (GDC-0068) | CFN60068 | 1001264-89-6 | 10mg | QQ客服:1457312923 |
| Ipatasertib (GDC-0068) | CFN60068 | 1001264-89-6 | 20mg | QQ客服:1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM in cell-free assays, 620-fold selectivity over PKA. |
| Targets: | Akt1/2/3 | PKA |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.1834 mL | 10.917 mL | 21.8341 mL | 43.6681 mL | 54.5852 mL |
| 5 mM | 0.4367 mL | 2.1834 mL | 4.3668 mL | 8.7336 mL | 10.917 mL |
| 10 mM | 0.2183 mL | 1.0917 mL | 2.1834 mL | 4.3668 mL | 5.4585 mL |
| 50 mM | 0.0437 mL | 0.2183 mL | 0.4367 mL | 0.8734 mL | 1.0917 mL |
| 100 mM | 0.0218 mL | 0.1092 mL | 0.2183 mL | 0.4367 mL | 0.5459 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 12-羟基杨梅酮; 12-Hydroxymyricanone | CFN91926 | 191999-68-5 | C21H24O6 = 372.41 | 5mg | QQ客服:1413575084 |
| Euchrestaflavanone B; Euchrestaflavanone B | CFN96525 | 87402-91-3 | C25H28O6 = 424.49 | 5mg | QQ客服:2056216494 |
| (-)-白花前胡素 A; (-)-Praeruptorin A | CFN89386 | 14017-71-1 | C21H22O7 = 386.39 | 5mg | QQ客服:215959384 |
| (-)-丁香树脂酚; (-)-Syringaresinol | CFN92500 | 6216-81-5 | C22H26O8 = 418.4 | 10mg | QQ客服:3257982914 |